🇺🇸 FDA
Pipeline program

Lifei Qingchang Granules

GMUCR2025-01009

Phase 2 small_molecule active

Quick answer

Lifei Qingchang Granules for Bronchiectasis is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Bronchiectasis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials